Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
暂无分享,去创建一个
S Chevret | S. Chevret | C. Degott | N. Ganne-Carrié | F. Degos | J. Trinchet | M. Beaugrand | C. Guettier | C. Christidis | C Degott | M Beaugrand | F Degos | C Christidis | N Ganne-Carrie | J P Farmachidi | C Guettier | J C Trinchet | Jean-Pierre Farmachidi | J. Farmachidi
[1] H. Thomas,et al. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C , 1997 .
[2] H. Tsukuma,et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. , 1993, The New England journal of medicine.
[3] M. Rapicetta,et al. Hepatitis C Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Patients with Cirrhosis , 1992, Annals of Internal Medicine.
[4] A. Pezzoli,et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. , 1996, Journal of hepatology.
[5] S. Seki,et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis , 1995, The Lancet.
[6] Richard E. Sampliner,et al. The Natural History of Community-Acquired Hepatitis C in the United States , 1993 .
[7] Neil Kaplowitz,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.
[8] N. Terrault,et al. Hepatitis C Virus in the Setting of Transplantation , 1995, Seminars in liver disease.
[9] M. Tong,et al. Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.
[10] M. Roncalli,et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. , 1995, Gastroenterology.
[11] W. Caselmann,et al. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. , 1996, Journal of hepatology.
[12] M. Mondelli,et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study , 1997, Hepatology.
[13] L. Benvegnu'. Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group. , 1998, Lancet.
[14] P. Marcellin,et al. Treatment of hepatitis C virus–related cirrhosis: A randomized, controlled trial of interferon alfa‐2b versus no treatment , 1999, Hepatology.
[15] R. Koretz,et al. Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade , 1993, Annals of Internal Medicine.
[16] K. Ishak,et al. Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis , 1991, Hepatology.
[17] P. Andersen,et al. Multistate models in survival analysis: a study of nephropathy and mortality in diabetes. , 1988, Statistics in medicine.
[18] Roger Williams,et al. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. , 1997, Journal of hepatology.
[19] C. Keirns,et al. Hepatitis C: a disease with a wide morphological spectrum? , 1996, Journal of clinical gastroenterology.
[20] R. Purcell,et al. NON-A, NON-B POST-TRANSFUSION HEPATITIS , 1977, The Lancet.
[21] A. Bhalla,et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.
[22] Ørnulf Borgan,et al. Counting process models for life history data: a review , 1984 .
[23] R. Purcell,et al. Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.
[24] K. Chayama,et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis , 1993, Hepatology.
[25] Y. Ohashi,et al. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA , 1999, Hepatology.
[26] G Realdi,et al. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). , 1997, Journal of hepatology.
[27] C. Chastang,et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis , 1996, Hepatology.
[28] F. Iber,et al. Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis , 1992 .
[29] O. Yokosuka,et al. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients , 1995, Hepatology.
[30] J. Pawlotsky,et al. Epidemiological factors affecting the severity of hepatitis C virus‐related liver disease: A French survey of 6,664 patients , 1997, Hepatology.
[31] O. Chazouilleres,et al. Determinants of outcome of compensated hepatitis C virus‐related cirrhosis , 1998, Hepatology.
[32] N. Hayashi,et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C , 1998, Hepatology.
[33] Y. Imai,et al. Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C , 1998, Annals of Internal Medicine.